Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Infusion related reactions in the phase 3 SOPHIA trial of margetuximab plus chemotherapy vs trastuzumab plus chemotherapy in patients with pretreated HER2+metastatic breast cancer Cortes, J., Cardoso, F., Curigliano, G., Gradishar, W. J., Im, S., Rugo, H. S., Bahadur, S. W., Falcone, A., Murillo, S., Riseberg, D. A., Musolino, A., Feinstein, T. M., Abreu, M. H., Im, Y., Novik, Y., Pluard, T., Salazar, L. G., Berardi, R., Pop, V., Hong, S., Jacobs, K., Rock, E., Pegram, M. D. AMER ASSOC CANCER RESEARCH. 2021
View details for Web of Science ID 000618737700286